A detailed history of Ubs Group Ag transactions in Chroma Dex Corp. stock. As of the latest transaction made, Ubs Group Ag holds 58,889 shares of CDXC stock, worth $312,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,889
Previous 139,746 57.86%
Holding current value
$312,111
Previous $381,000 43.83%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.51 - $3.8 $202,951 - $307,256
-80,857 Reduced 57.86%
58,889 $214,000
Q2 2024

Aug 13, 2024

BUY
$2.44 - $4.32 $292,124 - $517,203
119,723 Added 597.93%
139,746 $381,000
Q1 2024

May 13, 2024

BUY
$1.36 - $3.84 $25,255 - $71,308
18,570 Added 1278.05%
20,023 $69,000
Q4 2023

Feb 09, 2024

BUY
$1.28 - $1.6 $504 - $630
394 Added 37.2%
1,453 $2,000
Q3 2023

Nov 09, 2023

SELL
$1.36 - $1.77 $7,435 - $9,676
-5,467 Reduced 83.77%
1,059 $1,000
Q2 2023

Aug 11, 2023

SELL
$1.31 - $1.79 $14,526 - $19,849
-11,089 Reduced 62.95%
6,526 $10,000
Q1 2023

May 12, 2023

BUY
$1.48 - $2.19 $304 - $451
206 Added 1.18%
17,615 $26,000
Q4 2022

Feb 08, 2023

SELL
$1.25 - $1.94 $8,125 - $12,610
-6,500 Reduced 27.19%
17,409 $29,000
Q3 2022

Nov 10, 2022

SELL
$1.19 - $2.06 $614 - $1,062
-516 Reduced 2.11%
23,909 $29,000
Q2 2022

Aug 10, 2022

BUY
$1.59 - $2.7 $4,372 - $7,425
2,750 Added 12.69%
24,425 $41,000
Q1 2022

May 16, 2022

SELL
$2.02 - $3.92 $67,334 - $130,669
-33,334 Reduced 60.6%
21,675 $53,000
Q4 2021

Feb 14, 2022

BUY
$3.74 - $6.7 $8,934 - $16,006
2,389 Added 4.54%
55,009 $206,000
Q3 2021

Nov 15, 2021

SELL
$6.05 - $10.41 $283,146 - $487,198
-46,801 Reduced 47.07%
52,620 $330,000
Q2 2021

Aug 13, 2021

BUY
$6.66 - $10.92 $323,789 - $530,897
48,617 Added 95.7%
99,421 $980,000
Q1 2021

May 12, 2021

SELL
$4.59 - $18.74 $465,839 - $1.9 Million
-101,490 Reduced 66.64%
50,804 $474,000
Q4 2020

Feb 11, 2021

BUY
$3.93 - $5.5 $6,657 - $9,317
1,694 Added 1.12%
152,294 $731,000
Q3 2020

Nov 12, 2020

SELL
$4.01 - $5.56 $205,636 - $285,122
-51,281 Reduced 25.4%
150,600 $604,000
Q2 2020

Jul 31, 2020

SELL
$3.0 - $5.52 $55,614 - $102,329
-18,538 Reduced 8.41%
201,881 $926,000
Q1 2020

May 01, 2020

SELL
$2.54 - $4.75 $44,462 - $83,148
-17,505 Reduced 7.36%
220,419 $719,000
Q4 2019

Feb 14, 2020

BUY
$2.83 - $4.61 $79,157 - $128,946
27,971 Added 13.32%
237,924 $1.03 Million
Q3 2019

Nov 14, 2019

BUY
$3.83 - $4.72 $62,291 - $76,766
16,264 Added 8.4%
209,953 $826,000
Q2 2019

Aug 14, 2019

SELL
$3.71 - $4.83 $4,678 - $6,090
-1,261 Reduced 0.65%
193,689 $900,000
Q1 2019

May 14, 2019

BUY
$3.2 - $4.19 $136,342 - $178,523
42,607 Added 27.97%
194,950 $817,000
Q4 2018

Feb 14, 2019

BUY
$2.8 - $4.22 $20,386 - $30,725
7,281 Added 5.02%
152,343 $523,000
Q3 2018

Nov 14, 2018

SELL
$3.5 - $4.91 $2,247 - $3,152
-642 Reduced 0.44%
145,062 $623,000
Q2 2018

Aug 14, 2018

BUY
$3.22 - $4.43 $78,220 - $107,613
24,292 Added 20.01%
145,704 $541,000
Q1 2018

May 15, 2018

BUY
$4.05 - $6.46 $238,334 - $380,158
58,848 Added 94.06%
121,412 $510,000
Q4 2017

Feb 14, 2018

BUY
$3.88 - $6.96 $106,948 - $191,845
27,564 Added 78.75%
62,564 $368,000
Q3 2017

Nov 14, 2017

BUY
$2.91 - $4.71 $63,120 - $102,164
21,691 Added 162.98%
35,000 $151,000
Q2 2017

Aug 14, 2017

SELL
N/A
-6,174 Reduced 31.69%
13,309 $51,000
Q1 2017

Nov 14, 2017

BUY
N/A
19,483
19,483 $52,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $362M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.